bluebird bio, Inc.
News
bluebird bio, Inc. (NASDAQ:BLUE) Receives $4.74 Consensus Target Price from Analysts
Zolmax Shares of bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report) have earned an average rating of "Hold" from the twelve research firms that are presently covering the stock, Marketbeat Ratings reports...\n more…
bluebird bio, Inc. (NASDAQ:BLUE) Given Consensus Recommendation of "Hold" by Analysts
Ticker Report bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report) has been assigned a consensus recommendation of "Hold" from the twelve research firms that are covering the firm, MarketBeat.com reports. One...\n more…
bluebird bio (NASDAQ:BLUE) Stock Price Crosses Below 200-Day Moving Average of $1.06
Ticker Report bluebird bio, Inc. (NASDAQ:BLUE - Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.06 and traded...\n more…
bluebird bio, Inc. (NASDAQ:BLUE) Shares Sold by SG Americas Securities LLC
Ticker Report SG Americas Securities LLC lowered its position in bluebird bio, Inc. (NASDAQ:BLUE - Free Report) by 39.2% during the second quarter, according to its most recent 13F filing with the Securities and...\n more…
bluebird bio Announces September Investor Events
Business Wire bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will participate in fireside chats at the following upcoming investor conferences: 2024 Wells Fargo Healthcare...\n more…
